Briefs, Companies,

Sothema signs an agreement to buy Ramo Pharm

Drugmaker Sothema is to acquire the whole of Ramo Pharm, a Moroccan food supplement specialist, subject to approval by the Competition Council.

Sothema announced on 28 October 2026 that it had signed an agreement to acquire 100% of Ramo Pharm.

Founded in 1999 and based in Casablanca, Ramo Pharm sells food supplements in pharmacies, notably under the Enrouex, ZENmag, Toudex, Hivernex, CD Zinc and Matervit brands.

The deal remains subject to conditions, including approval by the Competition Council. The statement gives neither the price nor a completion date.

Read the profile of Sothema

Sources: Sothema, communiqué : acquisition de 100 % de Ramo Pharm, October 28, 2026; Le360, Sothema acquiert Ramo Pharm et se renforce dans les compléments alimentaires, October 28, 2026.

General information only. Nothing on this site constitutes investment advice or a recommendation to buy or sell.